等待开盘 11-18 09:30:00 美东时间
-2.960
-9.75%
11月18日,IDEAYA Biosciences(IDYA)收跌9.75%,报27.4美元,成交额5606.61万美元,市值26.49亿美元。 行情数据 •...
今天 06:19
Development candidate demonstrates encouraging preclinical activity in CDKN2A-deficienct tumor models as a monotherapy and in combination with inhibitors of RAS and MTAP, including IDEAYA's proprietary Phase 1 PRMT5 inhibitor IDE892 CDKN2A-deficiency is a common tumor suppressor loss prevalent in ~1...
11-16 13:19
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
11月10日,IDEAYA Biosciences(IDYA)收涨2.53%,报32.03美元,成交额2727.79万美元,市值30.97亿美元。 行情数据 ...
11-10 06:17
今日重点评级关注:康托·菲茨杰拉德:维持Supernus"超配"评级,目标价从67美元升至87美元;丰业银行:维持Atlas Energy Solutions"跑赢大市"评级,目标价从17美元升至18美元
11-05 14:06
Wedbush analyst Robert Driscoll maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $60 to $63.
11-04 22:28
华盛资讯11月4日讯,IDEAYA Biosciences公布2026财年Q3业绩,公司Q3营收0.10亿美元,同比下降95.1%,归母净利润亏损1.26亿美元,由盈转亏。
11-04 09:17
华盛资讯11月3日讯,IDEAYA Biosciences公布2026财年Q3业绩,公司Q3营收0.10亿美元,环比增长15.6%,归母净利润亏损1.26亿美元,环比亏损扩大11.8%。
11-03 21:19
IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(1.18) by 4.27 percent. This is a 191.73 percent decrease over earnings of $1.33 per share from the same period last year. The company reported quarterly sales of $10.242 m...
11-03 19:15
11月3日,IDEAYA Biosciences(IDYA)收跌1%,报31.64美元,成交额2494.01万美元,市值30.53亿美元。 行情数据 • 开盘价...
11-03 06:16